(Q40131794)

17 September 2017

A pharmacokinetic/pharmacodynamic mathematical model accurately describes the activity of voriconazole against Candida spp. in vitro (English)

1 reference

17 September 2017

1 reference

1 reference

1 reference

1 reference

7

Cornelius J Clancy

1 reference

17 September 2017

6

Hartmut Derendorf

1 reference

17 September 2017

Yanjun Li

1

1 reference

17 September 2017

M Hong Nguyen

2

1 reference

17 September 2017

Shaoji Cheng

3

1 reference

17 September 2017

Stephan Schmidt

4

1 reference

17 September 2017

Li Zhong

5

1 reference

17 September 2017

22 January 2008

1 reference

International Journal of Antimicrobial Agents

17 September 2017

1 reference

17 September 2017

31

1 reference

17 September 2017

4

1 reference

17 September 2017

369-374

1 reference

Pharmacokinetic/pharmacodynamic profile of voriconazole

17 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2367122

Voriconazole versus a regimen of amphotericin B followed by fluconazole for candidaemia in non-neutropenic patients: a randomised non-inferiority trial

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2367122

Pharmacokinetic/pharmacodynamic evaluation of anti-infective agents

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2367122

In vivo pharmacokinetics and pharmacodynamics of a new triazole, voriconazole, in a murine candidiasis model.

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2367122

Pharmacokinetics and safety of voriconazole following intravenous- to oral-dose escalation regimens

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2367122

Measurement of voriconazole activity against Candida albicans, C. glabrata, and C. parapsilosis isolates using time-kill methods validated by high-performance liquid chromatography

22 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2367122

Pharmacokinetic-pharmacodynamic modelling of antibacterial activity of cefpodoxime and cefixime in in vitro kinetic models

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2367122

Pharmacokinetic/pharmacodynamic modeling of in vitro activity of azithromycin against four different bacterial strains

20 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18215509

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.IJANTIMICAG.2007.11.015

1 reference

17 September 2017

1 reference

17 September 2017

1 reference